Catalyst Wire Dossier Catalyst Wire Dossier

Simotinib Hydrochloride

simotinib hydrochloride · Jiangsu Simcere Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Simotinib Hydrochloride, covering 2012-07-10 to 2015-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC [Phase 1]

See pricing